Gene: ARHGAP12
Official Full Name: Rho GTPase activating protein 12provided by HGNC
Gene Summary: This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein may be involved in suppressing tumor formation by regulating cell invasion and adhesion. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22060 | ARHGAP12 Knockout cell line (HeLa) | Human | ARHGAP12 | 1:3~1:6 | Negative | Online Inquiry |
KO22061 | ARHGAP12 Knockout cell line (HCT 116) | Human | ARHGAP12 | 1:2~1:4 | Negative | Online Inquiry |
KO22062 | ARHGAP12 Knockout cell line (HEK293) | Human | ARHGAP12 | 1:3~1:6 | Negative | Online Inquiry |
KO22063 | ARHGAP12 Knockout cell line (A549) | Human | ARHGAP12 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP12 Gene Knockout Cell Lines represent a specialized set of genetically modified cells designed to facilitate the functional study of the ARHGAP12 gene, a crucial regulatory element involved in various cellular processes such as cytoskeletal dynamics, cell adhesion, and signal transduction. These cell lines are engineered using CRISPR/Cas9 technology to specifically disrupt the ARHGAP12 gene, providing researchers with a powerful tool to investigate the gene's role in health and disease.
The primary mechanism of action for these knockout cell lines lies in the inactivation of ARHGAP12, leading to altered cellular functions associated with the Rho GTPase signaling pathways. This disruption can significantly impact cellular morphology, motility, and growth, making it essential for studies in cancer biology, developmental biology, and neurobiology. By observing the consequences of ARHGAP12 gene knockout, researchers can uncover insights into its regulatory functions and its potential implications in oncogenic processes and other pathologies.
The scientific importance of ARHGAP12 Gene Knockout Cell Lines is underscored by their applications in both basic research and potential therapeutic settings. These models allow for the exploration of novel therapeutic targets and can accelerate drug discovery processes by providing insight into how ARHGAP12 modulation affects disease states. They uniquely enable the study of gene function in a controlled environment, thus contributing to advancements in personalized medicine and targeted therapies.
Compared to alternative methods such as siRNA knockdown or pharmacological inhibition, the use of gene knockout models offers a more stable and permanent alteration, allowing for long-term studies of cellular phenotype and behavior. This reliability ensures reproducibility and depth in research findings, reducing the noise associated with transient gene silencing techniques.
For researchers and clinicians striving to elucidate the complexities of gene functions, ARHGAP12 Gene Knockout Cell Lines serve as a critical asset, paving the way for groundbreaking discoveries that may lead to improved therapeutic interventions. With our commitment to excellence and expertise in providing advanced biological products, we ensure that our cell lines are meticulously validated and optimized for reproducibility, making them an invaluable tool for the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.